Bruce C Cozadd is Chairman & CEO of Jazz Pharmaceuticals plc. Currently has a direct ownership of 429,809 shares of JAZZ, which is worth approximately $47.7 Million. The most recent transaction as insider was on Mar 17, 2022, when has been sold 1,288 shares (Ordinary Shares) at a price of $59.13 per share, resulting in proceeds of $76,159. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 430K
0% 3M change
10.89% 12M change
Total Value Held $47.7 Million

BRUCE C COZADD Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 17 2022
BUY
Exercise of conversion of derivative security
$76,159 $59.13 p/Share
1,288 Added 0.37%
347,134 Ordinary Shares
Mar 05 2022
SELL
Payment of exercise price or tax liability
$3,376,189 $153.96 p/Share
21,929 Reduced 5.96%
345,846 Ordinary Shares
Mar 03 2022
BUY
Grant, award, or other acquisition
-
44,788 Added 10.86%
367,775 Ordinary Shares
Mar 02 2022
SELL
Open market or private sale
$900,000 $150.0 p/Share
6,000 Reduced 1.82%
322,987 Ordinary Shares
Mar 01 2022
SELL
Open market or private sale
$888,167 $136.62 p/Share
6,501 Reduced 1.94%
328,987 Ordinary Shares
Mar 01 2022
BUY
Exercise of conversion of derivative security
$454,251 $46.83 p/Share
9,700 Added 2.81%
335,488 Ordinary Shares
Feb 01 2022
SELL
Open market or private sale
$886,982 $139.2 p/Share
6,372 Reduced 1.92%
325,788 Ordinary Shares
Feb 01 2022
BUY
Exercise of conversion of derivative security
$454,251 $46.83 p/Share
9,700 Added 2.84%
332,160 Ordinary Shares
Jan 03 2022
SELL
Open market or private sale
$741,711 $128.08 p/Share
5,791 Reduced 1.76%
322,460 Ordinary Shares
Jan 03 2022
BUY
Exercise of conversion of derivative security
$454,251 $46.83 p/Share
9,700 Added 2.87%
328,251 Ordinary Shares
Dec 01 2021
SELL
Open market or private sale
$828,115 $122.72 p/Share
6,748 Reduced 2.07%
318,551 Ordinary Shares
Dec 01 2021
BUY
Exercise of conversion of derivative security
$454,251 $46.83 p/Share
9,700 Added 2.9%
325,299 Ordinary Shares
Nov 01 2021
SELL
Open market or private sale
$882,700 $134.64 p/Share
6,556 Reduced 2.04%
315,536 Ordinary Shares
Nov 01 2021
BUY
Exercise of conversion of derivative security
$454,251 $46.83 p/Share
9,700 Added 2.92%
322,092 Ordinary Shares
Oct 04 2021
SELL
Open market or private sale
$856,882 $129.87 p/Share
6,598 Reduced 2.07%
312,392 Ordinary Shares
Oct 04 2021
BUY
Exercise of conversion of derivative security
$454,251 $46.83 p/Share
9,700 Added 2.95%
318,990 Ordinary Shares
Sep 01 2021
SELL
Open market or private sale
$65,790 $131.58 p/Share
500 Reduced 0.16%
309,290 Ordinary Shares
Aug 05 2021
BUY
Exercise of conversion of derivative security
$124,193 $46.83 p/Share
2,652 Added 0.85%
309,790 Ordinary Shares
Aug 02 2021
SELL
Open market or private sale
$297,483 $169.99 p/Share
1,750 Reduced 0.57%
307,138 Ordinary Shares
Jul 01 2021
SELL
Open market or private sale
$1,960,269 $180.67 p/Share
10,850 Reduced 3.39%
308,888 Ordinary Shares
Jun 01 2021
SELL
Open market or private sale
$313,373 $179.07 p/Share
1,750 Reduced 0.54%
319,738 Ordinary Shares
May 05 2021
SELL
Open market or private sale
$85,000 $170.0 p/Share
500 Reduced 0.16%
321,341 Ordinary Shares
May 03 2021
SELL
Open market or private sale
$246,360 $164.24 p/Share
1,500 Reduced 0.46%
321,841 Ordinary Shares
Apr 01 2021
SELL
Open market or private sale
$247,440 $164.96 p/Share
1,500 Reduced 0.46%
323,341 Ordinary Shares
Mar 05 2021
SELL
Payment of exercise price or tax liability
$3,544,761 $164.75 p/Share
21,516 Reduced 6.21%
324,841 Ordinary Shares

Also insider at

SLRN
ACELYRIN, Inc.
BCC

Bruce C Cozadd

Chairman & CEO
Dublin 4, L2

Track Institutional and Insider Activities on JAZZ

Follow Jazz Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JAZZ shares.

Notify only if

Insider Trading

Get notified when an Jazz Pharmaceuticals PLC insider buys or sells JAZZ shares.

Notify only if

News

Receive news related to Jazz Pharmaceuticals plc

Track Activities on JAZZ